Pharmanutra
Develops and distributes nutritional supplements and medical devices based on research.
PHN | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005274094
- LEI:
- 815600F8217BC7733697
- Country:
- Italy
- Address:
- VIA CAMPODAVELA, 1, 56122 PISA
- Website:
- http://www.pharmanutra.it
- Sector:
- Manufacturing
Description
PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-10 18:17 |
PHN - Initiation of share buy-back program
|
English | 195.3 KB | ||
| 2023-10-10 18:16 |
PHN - Avvio programma azioni proprie
|
Italian | 195.2 KB | ||
| 2023-10-03 18:05 |
PR - FIRST SALES ON THE US MARKET
|
English | 191.8 KB | ||
| 2023-10-03 18:00 |
CS - PRIME VENDITE SUL MERCATO AMERICANO
|
Italian | 192.7 KB | ||
| 2023-09-19 10:16 |
INTERIM MANAGEMENT REPORT AS AT 30 JUNE 2023
|
English | 2.3 MB | ||
| 2023-09-19 10:14 |
RELAZIONE FINANZIARIA SEMESTRALE AL 30 GIUGNO 2023
|
Italian | 2.2 MB | ||
| 2023-09-19 10:12 |
Half-Year Financial Report as of 30 June 2023
|
English | 202.1 KB | ||
| 2023-09-19 10:10 |
PHN-Pubblicazione della Relazione Finanziaria Semestrale al 30 giugno 2023
|
Italian | 202.3 KB | ||
| 2023-09-11 17:50 |
FIRST HALF 2023 RESULTS
|
English | 291.1 KB | ||
| 2023-09-11 17:45 |
RISULTATI PRIMO SEMESTRE 2023
|
Italian | 294.1 KB | ||
| 2023-08-30 18:03 |
PR - Lipocet to be classified as a Novel Food also in UK
|
English | 212.0 KB | ||
| 2023-08-30 17:58 |
CS - Lipocet autorizzata la classificazione come Novel Food nel Regno Unito
|
Italian | 215.1 KB | ||
| 2023-07-17 18:12 |
PR PHARMANUTRA - PHN - THE BOARD OF DIRECTOR APPROVES THE 2022 SUSTAINABILITY R…
|
English | 242.5 KB | ||
| 2023-07-17 18:05 |
CS PHARMANUTRA - PHN - APPROVAZIONE BILANCIO DI SOSTENIBILITA' 2022
|
Italian | 247.1 KB | ||
| 2023-05-26 18:21 |
PR - PHARMANUTRA - PHN - CETILAR SIDE BY SIDE WITH FERNANDO ALONSO
|
English | 421.5 KB |
Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharmanutra
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharmanutra via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
